nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—NFKB1—allergic rhinitis	0.515	1	CbGaD
Thalidomide—PTGS1—Montelukast—allergic rhinitis	0.0291	0.0967	CbGbCtD
Thalidomide—PTGS1—Diphenhydramine—allergic rhinitis	0.0291	0.0967	CbGbCtD
Thalidomide—CYP2C19—Desloratadine—allergic rhinitis	0.0245	0.0815	CbGbCtD
Thalidomide—PTGS2—Triamcinolone—allergic rhinitis	0.0239	0.0794	CbGbCtD
Thalidomide—CYP1A2—Desloratadine—allergic rhinitis	0.0226	0.0752	CbGbCtD
Thalidomide—PTGS2—Betamethasone—allergic rhinitis	0.0205	0.0681	CbGbCtD
Thalidomide—CYP2C9—Desloratadine—allergic rhinitis	0.0204	0.0678	CbGbCtD
Thalidomide—CYP2C19—Loratadine—allergic rhinitis	0.0141	0.0468	CbGbCtD
Thalidomide—CYP2C19—Diphenhydramine—allergic rhinitis	0.0141	0.0468	CbGbCtD
Thalidomide—CYP1A2—Diphenhydramine—allergic rhinitis	0.013	0.0432	CbGbCtD
Thalidomide—PTGS2—Dexamethasone—allergic rhinitis	0.0119	0.0396	CbGbCtD
Thalidomide—CYP2C9—Loratadine—allergic rhinitis	0.0117	0.0389	CbGbCtD
Thalidomide—CYP2C9—Diphenhydramine—allergic rhinitis	0.0117	0.0389	CbGbCtD
Thalidomide—CYP2C9—Montelukast—allergic rhinitis	0.0117	0.0389	CbGbCtD
Thalidomide—CYP1A1—Dexamethasone—allergic rhinitis	0.0101	0.0335	CbGbCtD
Thalidomide—CYP3A5—Hydrocortisone—allergic rhinitis	0.00972	0.0323	CbGbCtD
Thalidomide—CYP2E1—Dexamethasone—allergic rhinitis	0.00778	0.0258	CbGbCtD
Thalidomide—CYP3A5—Dexamethasone—allergic rhinitis	0.00604	0.0201	CbGbCtD
Thalidomide—CYP2C19—Dexamethasone—allergic rhinitis	0.00487	0.0162	CbGbCtD
Thalidomide—CYP2C9—Dexamethasone—allergic rhinitis	0.00405	0.0135	CbGbCtD
Thalidomide—FGFR2—exocrine gland—allergic rhinitis	0.00218	0.0925	CbGeAlD
Thalidomide—NFKB1—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.0018	0.0484	CbGpPWpGaD
Thalidomide—NFKB1—respiratory system—allergic rhinitis	0.00151	0.0641	CbGeAlD
Thalidomide—NFKB1—IL1 and megakaryotyces in obesity—TLR1—allergic rhinitis	0.00144	0.0388	CbGpPWpGaD
Thalidomide—NFKB1—eye—allergic rhinitis	0.00138	0.0586	CbGeAlD
Thalidomide—CRBN—respiratory system—allergic rhinitis	0.00126	0.0537	CbGeAlD
Thalidomide—NFKB1—bronchus—allergic rhinitis	0.00124	0.0527	CbGeAlD
Thalidomide—FGFR2—respiratory system—allergic rhinitis	0.00113	0.0481	CbGeAlD
Thalidomide—NFKB1—trachea—allergic rhinitis	0.00111	0.0474	CbGeAlD
Thalidomide—CRBN—bronchus—allergic rhinitis	0.00104	0.0442	CbGeAlD
Thalidomide—FGFR2—eye—allergic rhinitis	0.00103	0.044	CbGeAlD
Thalidomide—FGFR2—epithelium—allergic rhinitis	0.000946	0.0402	CbGeAlD
Thalidomide—CRBN—trachea—allergic rhinitis	0.000934	0.0397	CbGeAlD
Thalidomide—FGFR2—skin of body—allergic rhinitis	0.0009	0.0383	CbGeAlD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL15—allergic rhinitis	0.000887	0.0238	CbGpPWpGaD
Thalidomide—NFKB1—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.000839	0.0225	CbGpPWpGaD
Thalidomide—NFKB1—lung—allergic rhinitis	0.000801	0.034	CbGeAlD
Thalidomide—NFKB1—IL17 signaling pathway—IL17A—allergic rhinitis	0.000675	0.0181	CbGpPWpGaD
Thalidomide—CRBN—lung—allergic rhinitis	0.000671	0.0285	CbGeAlD
Thalidomide—NFKB1—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.000666	0.0179	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL13—allergic rhinitis	0.000624	0.0168	CbGpPWpGaD
Thalidomide—TNF—Type II diabetes mellitus—ADIPOQ—allergic rhinitis	0.000609	0.0164	CbGpPWpGaD
Thalidomide—TNF—Transcription factor regulation in adipogenesis—ADIPOQ—allergic rhinitis	0.000609	0.0164	CbGpPWpGaD
Thalidomide—FGFR2—lung—allergic rhinitis	0.000601	0.0256	CbGeAlD
Thalidomide—TNF—IL27-mediated signaling events—IL17A—allergic rhinitis	0.000592	0.0159	CbGpPWpGaD
Thalidomide—NFKB1—IL23-mediated signaling events—IL17A—allergic rhinitis	0.000586	0.0157	CbGpPWpGaD
Thalidomide—NFKB1—TFs Regulate miRNAs related to cardiac hypertrophy—TGFB1—allergic rhinitis	0.000553	0.0149	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL5—allergic rhinitis	0.000534	0.0143	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.000453	0.0122	CbGpPWpGaD
Thalidomide—TNF—IL23-mediated signaling events—IL17A—allergic rhinitis	0.000446	0.012	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.000446	0.012	CbGpPWpGaD
Thalidomide—PTGS2—Fluocinonide—Flunisolide—allergic rhinitis	0.000444	0.213	CbGdCrCtD
Thalidomide—NFKB1—IL1 and megakaryotyces in obesity—ICAM1—allergic rhinitis	0.000435	0.0117	CbGpPWpGaD
Thalidomide—CYP1A2—respiratory system—allergic rhinitis	0.000416	0.0177	CbGeAlD
Thalidomide—CYP1A1—respiratory system—allergic rhinitis	0.00041	0.0174	CbGeAlD
Thalidomide—CYP3A5—respiratory system—allergic rhinitis	0.000401	0.017	CbGeAlD
Thalidomide—NFKB1—CD40/CD40L signaling—IL4—allergic rhinitis	0.000396	0.0106	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL10—allergic rhinitis	0.00039	0.0105	CbGpPWpGaD
Thalidomide—NFKB1—Downstream TCR signaling—HLA-DQB1—allergic rhinitis	0.000389	0.0104	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL4—allergic rhinitis	0.00038	0.0102	CbGpPWpGaD
Thalidomide—CYP2E1—respiratory system—allergic rhinitis	0.000374	0.0159	CbGeAlD
Thalidomide—PTGS1—respiratory system—allergic rhinitis	0.00036	0.0153	CbGeAlD
Thalidomide—NFKB1—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000358	0.00961	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.000354	0.00951	CbGpPWpGaD
Thalidomide—NFKB1—amb2 Integrin signaling—ICAM1—allergic rhinitis	0.000346	0.00929	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.000345	0.00928	CbGpPWpGaD
Thalidomide—PTGS2—respiratory system—allergic rhinitis	0.000344	0.0146	CbGeAlD
Thalidomide—CYP1A1—epithelium—allergic rhinitis	0.000343	0.0146	CbGeAlD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.00034	0.00912	CbGpPWpGaD
Thalidomide—CYP1A1—bronchus—allergic rhinitis	0.000337	0.0143	CbGeAlD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—IL13—allergic rhinitis	0.000337	0.00905	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000326	0.00876	CbGpPWpGaD
Thalidomide—CYP1A1—skin of body—allergic rhinitis	0.000326	0.0138	CbGeAlD
Thalidomide—TNF—Allograft Rejection—FOXP3—allergic rhinitis	0.000309	0.00831	CbGpPWpGaD
Thalidomide—CYP1A1—trachea—allergic rhinitis	0.000303	0.0129	CbGeAlD
Thalidomide—PTGS1—epithelium—allergic rhinitis	0.000301	0.0128	CbGeAlD
Thalidomide—NFKB1—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—allergic rhinitis	0.000294	0.00789	CbGpPWpGaD
Thalidomide—NFKB1—TCR signaling—HLA-DQB1—allergic rhinitis	0.00029	0.0078	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—IL5—allergic rhinitis	0.000288	0.00774	CbGpPWpGaD
Thalidomide—NFKB1—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000288	0.00773	CbGpPWpGaD
Thalidomide—PTGS2—epithelium—allergic rhinitis	0.000288	0.0122	CbGeAlD
Thalidomide—NFKB1—IL-4 Signaling Pathway—IL4—allergic rhinitis	0.000286	0.00769	CbGpPWpGaD
Thalidomide—PTGS1—skin of body—allergic rhinitis	0.000286	0.0122	CbGeAlD
Thalidomide—NFKB1—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000283	0.00761	CbGpPWpGaD
Thalidomide—PTGS2—bronchus—allergic rhinitis	0.000283	0.012	CbGeAlD
Thalidomide—TNF—Allograft Rejection—HLA-G—allergic rhinitis	0.000281	0.00754	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.000276	0.00741	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—PFN2—allergic rhinitis	0.000274	0.00736	CbGpPWpGaD
Thalidomide—PTGS2—skin of body—allergic rhinitis	0.000274	0.0116	CbGeAlD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.00027	0.00724	CbGpPWpGaD
Thalidomide—PTGS2—Fluticasone Propionate—Flunisolide—allergic rhinitis	0.000268	0.129	CbGdCrCtD
Thalidomide—PTGS1—trachea—allergic rhinitis	0.000266	0.0113	CbGeAlD
Thalidomide—TNF—Allograft Rejection—IL13—allergic rhinitis	0.000264	0.00711	CbGpPWpGaD
Thalidomide—TNF—amb2 Integrin signaling—ICAM1—allergic rhinitis	0.000263	0.00708	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—IL4—allergic rhinitis	0.000263	0.00707	CbGpPWpGaD
Thalidomide—PTGS2—trachea—allergic rhinitis	0.000254	0.0108	CbGeAlD
Thalidomide—NFKB1—Folate Metabolism—IL4—allergic rhinitis	0.000244	0.00655	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—IL17A—allergic rhinitis	0.000243	0.00654	CbGpPWpGaD
Thalidomide—NFKB1—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.000241	0.00648	CbGpPWpGaD
Thalidomide—NFKB1—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.000238	0.0064	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000236	0.00633	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.000232	0.00623	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—IL5—allergic rhinitis	0.000231	0.00621	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—IL5—allergic rhinitis	0.000226	0.00608	CbGpPWpGaD
Thalidomide—NFKB1—IL23-mediated signaling events—CD4—allergic rhinitis	0.000226	0.00608	CbGpPWpGaD
Thalidomide—NFKB1—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000224	0.00602	CbGpPWpGaD
Thalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—allergic rhinitis	0.000224	0.00601	CbGpPWpGaD
Thalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000222	0.00596	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—CD4—allergic rhinitis	0.000222	0.00596	CbGpPWpGaD
Thalidomide—CYP1A2—lung—allergic rhinitis	0.000221	0.00938	CbGeAlD
Thalidomide—CYP1A1—lung—allergic rhinitis	0.000218	0.00925	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Methylprednisolone—allergic rhinitis	0.000217	0.104	CbGdCrCtD
Thalidomide—TNF—Canonical NF-kappaB pathway—NFKB1—allergic rhinitis	0.000217	0.00584	CbGpPWpGaD
Thalidomide—TNF—EBV LMP1 signaling—NFKB1—allergic rhinitis	0.000217	0.00584	CbGpPWpGaD
Thalidomide—TNF—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000216	0.0058	CbGpPWpGaD
Thalidomide—PTGS2—Fluocinonide—Betamethasone—allergic rhinitis	0.000214	0.103	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Dexamethasone—allergic rhinitis	0.000214	0.103	CbGdCrCtD
Thalidomide—CYP3A5—lung—allergic rhinitis	0.000213	0.00904	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Triamcinolone—allergic rhinitis	0.000209	0.1	CbGdCrCtD
Thalidomide—TNF—Developmental Biology—PFN2—allergic rhinitis	0.000209	0.00561	CbGpPWpGaD
Thalidomide—NFKB1—Downstream TCR signaling—CD4—allergic rhinitis	0.000208	0.0056	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—IL4—allergic rhinitis	0.000205	0.00551	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000202	0.00542	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000201	0.00541	CbGpPWpGaD
Thalidomide—CYP2E1—lung—allergic rhinitis	0.000198	0.00843	CbGeAlD
Thalidomide—NFKB1—Folate Metabolism—ICAM1—allergic rhinitis	0.000194	0.00521	CbGpPWpGaD
Thalidomide—PTGS1—lung—allergic rhinitis	0.000191	0.00813	CbGeAlD
Thalidomide—TNF—Folate Metabolism—IL4—allergic rhinitis	0.000186	0.00499	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000185	0.00498	CbGpPWpGaD
Thalidomide—PTGS2—lung—allergic rhinitis	0.000183	0.00777	CbGeAlD
Thalidomide—TNF—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.000181	0.00487	CbGpPWpGaD
Thalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.00018	0.00483	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000175	0.00471	CbGpPWpGaD
Thalidomide—TNF—IL23-mediated signaling events—CD4—allergic rhinitis	0.000172	0.00463	CbGpPWpGaD
Thalidomide—FGFR2—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—allergic rhinitis	0.000167	0.00449	CbGpPWpGaD
Thalidomide—TNF—amb2 Integrin signaling—NFKB1—allergic rhinitis	0.000167	0.00448	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—IL10—allergic rhinitis	0.000165	0.00444	CbGpPWpGaD
Thalidomide—TNF—IL27-mediated signaling events—TGFB1—allergic rhinitis	0.000164	0.00441	CbGpPWpGaD
Thalidomide—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—allergic rhinitis	0.000164	0.00441	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—ICAM1—allergic rhinitis	0.000163	0.00438	CbGpPWpGaD
Thalidomide—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—allergic rhinitis	0.000163	0.00437	CbGpPWpGaD
Thalidomide—NFKB1—DNA Damage Response (only ATM dependent)—SMAD3—allergic rhinitis	0.000162	0.00434	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—IL4—allergic rhinitis	0.000161	0.00432	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—TGFB1—allergic rhinitis	0.000159	0.00428	CbGpPWpGaD
Thalidomide—NFKB1—TCR signaling—CD4—allergic rhinitis	0.000156	0.00418	CbGpPWpGaD
Thalidomide—NFKB1—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000154	0.00414	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—CD4—allergic rhinitis	0.000154	0.00413	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000153	0.00412	CbGpPWpGaD
Thalidomide—TNF—IL23-mediated signaling events—NFKB1—allergic rhinitis	0.000148	0.00399	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—ICAM1—allergic rhinitis	0.000148	0.00397	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—ADIPOQ—allergic rhinitis	0.000147	0.00395	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.000144	0.00386	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000141	0.00379	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—MS4A2—allergic rhinitis	0.000139	0.00374	CbGpPWpGaD
Thalidomide—FGFR2—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000135	0.00362	CbGpPWpGaD
Thalidomide—TNF—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000134	0.00361	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000134	0.0036	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—MS4A2—allergic rhinitis	0.000132	0.00354	CbGpPWpGaD
Thalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	0.000131	0.063	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	0.000129	0.062	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Betamethasone—allergic rhinitis	0.000129	0.062	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	0.000126	0.0606	CbGdCrCtD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000126	0.00338	CbGpPWpGaD
Thalidomide—TNF—TNF receptor signaling pathway —NFKB1—allergic rhinitis	0.000125	0.00335	CbGpPWpGaD
Thalidomide—TNF—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000125	0.00335	CbGpPWpGaD
Thalidomide—TNF—Ceramide signaling pathway—NFKB1—allergic rhinitis	0.000121	0.00324	CbGpPWpGaD
Thalidomide—NFKB1—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	0.00012	0.00322	CbGpPWpGaD
Thalidomide—NFKB1—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000118	0.00318	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000117	0.00315	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—IL4—allergic rhinitis	0.000117	0.00314	CbGpPWpGaD
Thalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	0.000117	0.00314	CbGpPWpGaD
Thalidomide—TNF—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	0.000115	0.00309	CbGpPWpGaD
Thalidomide—FGFR2—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000112	0.00301	CbGpPWpGaD
Thalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—allergic rhinitis	0.000111	0.00299	CbGpPWpGaD
Thalidomide—NFKB1—TCR Signaling Pathway—CD4—allergic rhinitis	0.000111	0.00299	CbGpPWpGaD
Thalidomide—TNF—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	0.00011	0.00295	CbGpPWpGaD
Thalidomide—TNF—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000108	0.00291	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000108	0.0029	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—SMAD3—allergic rhinitis	0.000107	0.00287	CbGpPWpGaD
Thalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000104	0.00279	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of Telomerase—TGFB1—allergic rhinitis	9.98e-05	0.00268	CbGpPWpGaD
Thalidomide—CYP1A1—Melatonin metabolism and effects—NFKB1—allergic rhinitis	9.9e-05	0.00266	CbGpPWpGaD
Thalidomide—CYP1A1—Oxidative Stress—NFKB1—allergic rhinitis	9.64e-05	0.00259	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL10—allergic rhinitis	9.6e-05	0.00258	CbGpPWpGaD
Thalidomide—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	9.6e-05	0.00258	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—NFKB1—allergic rhinitis	9.35e-05	0.00251	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—ICAM1—allergic rhinitis	9.27e-05	0.00249	CbGpPWpGaD
Thalidomide—TNF—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	9.14e-05	0.00246	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—ICAM1—allergic rhinitis	9.14e-05	0.00245	CbGpPWpGaD
Thalidomide—NFKB1—Transcriptional regulation of white adipocyte differentiation—TGFB1—allergic rhinitis	9.03e-05	0.00243	CbGpPWpGaD
Thalidomide—TNF—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	9.01e-05	0.00242	CbGpPWpGaD
Thalidomide—TNF—Signaling events mediated by HDAC Class I—NFKB1—allergic rhinitis	8.92e-05	0.0024	CbGpPWpGaD
Thalidomide—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	8.43e-05	0.00226	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	8.36e-05	0.00224	CbGpPWpGaD
Thalidomide—FGFR2—Neural Crest Differentiation—NFKB1—allergic rhinitis	8.28e-05	0.00223	CbGpPWpGaD
Thalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—allergic rhinitis	8.26e-05	0.00222	CbGpPWpGaD
Thalidomide—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	8.11e-05	0.00218	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—MS4A2—allergic rhinitis	8.1e-05	0.00218	CbGpPWpGaD
Thalidomide—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	7.99e-05	0.00215	CbGpPWpGaD
Thalidomide—NFKB1—TCR Signaling Pathway—TGFB1—allergic rhinitis	7.97e-05	0.00214	CbGpPWpGaD
Thalidomide—NFKB1—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	7.83e-05	0.0021	CbGpPWpGaD
Thalidomide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	7.72e-05	0.00207	CbGpPWpGaD
Thalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	7.71e-05	0.00207	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—NFKB1—allergic rhinitis	7.71e-05	0.00207	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—MS4A2—allergic rhinitis	7.68e-05	0.00206	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—NFKB1—allergic rhinitis	7.42e-05	0.00199	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—allergic rhinitis	7.25e-05	0.00195	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL4—allergic rhinitis	7.22e-05	0.00194	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—HLA-G—allergic rhinitis	7.21e-05	0.00194	CbGpPWpGaD
Thalidomide—TNF—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	7.17e-05	0.00193	CbGpPWpGaD
Thalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—allergic rhinitis	6.88e-05	0.00185	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	6.85e-05	0.00184	CbGpPWpGaD
Thalidomide—NFKB1—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	6.84e-05	0.00184	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—HLA-G—allergic rhinitis	6.84e-05	0.00184	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—TGFB1—allergic rhinitis	6.74e-05	0.00181	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—ADIPOQ—allergic rhinitis	6.64e-05	0.00178	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	6.6e-05	0.00177	CbGpPWpGaD
Thalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	6.42e-05	0.00172	CbGpPWpGaD
Thalidomide—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	6.32e-05	0.0017	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	6.1e-05	0.00164	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—NFKB1—allergic rhinitis	5.78e-05	0.00155	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—ICAM1—allergic rhinitis	5.74e-05	0.00154	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	5.7e-05	0.00153	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	5.54e-05	0.00149	CbGpPWpGaD
Thalidomide—PTGS2—C-MYB transcription factor network—CD4—allergic rhinitis	5.53e-05	0.00149	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	5.29e-05	0.00142	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	5.15e-05	0.00138	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—ADIPOQ—allergic rhinitis	5.06e-05	0.00136	CbGpPWpGaD
Thalidomide—FGFR2—B Cell Activation—NFKB1—allergic rhinitis	4.89e-05	0.00131	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—TGFB1—allergic rhinitis	4.89e-05	0.00131	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	4.84e-05	0.0013	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—SMAD3—allergic rhinitis	4.82e-05	0.0013	CbGpPWpGaD
Thalidomide—Arrhythmia—Triamcinolone—allergic rhinitis	4.71e-05	0.000388	CcSEcCtD
Thalidomide—Vision blurred—Prednisolone—allergic rhinitis	4.7e-05	0.000388	CcSEcCtD
Thalidomide—Arrhythmia—Methylprednisolone—allergic rhinitis	4.7e-05	0.000388	CcSEcCtD
Thalidomide—TNF—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	4.7e-05	0.00126	CbGpPWpGaD
Thalidomide—Vomiting—Montelukast—allergic rhinitis	4.68e-05	0.000386	CcSEcCtD
Thalidomide—Rash—Montelukast—allergic rhinitis	4.64e-05	0.000383	CcSEcCtD
Thalidomide—Dermatitis—Montelukast—allergic rhinitis	4.64e-05	0.000383	CcSEcCtD
Thalidomide—Ill-defined disorder—Prednisolone—allergic rhinitis	4.63e-05	0.000382	CcSEcCtD
Thalidomide—Headache—Montelukast—allergic rhinitis	4.61e-05	0.000381	CcSEcCtD
Thalidomide—Visual impairment—Betamethasone—allergic rhinitis	4.61e-05	0.00038	CcSEcCtD
Thalidomide—Visual impairment—Dexamethasone—allergic rhinitis	4.61e-05	0.00038	CcSEcCtD
Thalidomide—Mental disorder—Methylprednisolone—allergic rhinitis	4.61e-05	0.00038	CcSEcCtD
Thalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—allergic rhinitis	4.59e-05	0.00123	CbGpPWpGaD
Thalidomide—Malnutrition—Methylprednisolone—allergic rhinitis	4.58e-05	0.000378	CcSEcCtD
Thalidomide—Angioedema—Prednisolone—allergic rhinitis	4.56e-05	0.000376	CcSEcCtD
Thalidomide—TNF—Adipogenesis—TGFB1—allergic rhinitis	4.53e-05	0.00122	CbGpPWpGaD
Thalidomide—Ill-defined disorder—Hydrocortisone—allergic rhinitis	4.52e-05	0.000373	CcSEcCtD
Thalidomide—NFKB1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.5e-05	0.00121	CbGpPWpGaD
Thalidomide—Malaise—Prednisolone—allergic rhinitis	4.5e-05	0.000371	CcSEcCtD
Thalidomide—Dysgeusia—Triamcinolone—allergic rhinitis	4.49e-05	0.000371	CcSEcCtD
Thalidomide—Vertigo—Prednisolone—allergic rhinitis	4.48e-05	0.00037	CcSEcCtD
Thalidomide—Syncope—Prednisolone—allergic rhinitis	4.47e-05	0.000369	CcSEcCtD
Thalidomide—Eye disorder—Dexamethasone—allergic rhinitis	4.47e-05	0.000369	CcSEcCtD
Thalidomide—Eye disorder—Betamethasone—allergic rhinitis	4.47e-05	0.000369	CcSEcCtD
Thalidomide—Angioedema—Hydrocortisone—allergic rhinitis	4.45e-05	0.000367	CcSEcCtD
Thalidomide—NFKB1—Signaling Pathways—PTGDR2—allergic rhinitis	4.45e-05	0.0012	CbGpPWpGaD
Thalidomide—Back pain—Triamcinolone—allergic rhinitis	4.44e-05	0.000366	CcSEcCtD
Thalidomide—TNF—MAPK Signaling Pathway—NFKB1—allergic rhinitis	4.43e-05	0.00119	CbGpPWpGaD
Thalidomide—Malaise—Hydrocortisone—allergic rhinitis	4.39e-05	0.000362	CcSEcCtD
Thalidomide—Loss of consciousness—Prednisolone—allergic rhinitis	4.38e-05	0.000362	CcSEcCtD
Thalidomide—Vertigo—Hydrocortisone—allergic rhinitis	4.38e-05	0.000361	CcSEcCtD
Thalidomide—Nausea—Montelukast—allergic rhinitis	4.37e-05	0.000361	CcSEcCtD
Thalidomide—NFKB1—Immune System—HLA-G—allergic rhinitis	4.37e-05	0.00117	CbGpPWpGaD
Thalidomide—Syncope—Hydrocortisone—allergic rhinitis	4.37e-05	0.00036	CcSEcCtD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	4.37e-05	0.00117	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	4.37e-05	0.00117	CbGpPWpGaD
Thalidomide—Angiopathy—Dexamethasone—allergic rhinitis	4.34e-05	0.000358	CcSEcCtD
Thalidomide—Angiopathy—Betamethasone—allergic rhinitis	4.34e-05	0.000358	CcSEcCtD
Thalidomide—Convulsion—Prednisolone—allergic rhinitis	4.32e-05	0.000357	CcSEcCtD
Thalidomide—Hypertension—Prednisolone—allergic rhinitis	4.31e-05	0.000355	CcSEcCtD
Thalidomide—Loss of consciousness—Hydrocortisone—allergic rhinitis	4.28e-05	0.000353	CcSEcCtD
Thalidomide—Arrhythmia—Dexamethasone—allergic rhinitis	4.27e-05	0.000352	CcSEcCtD
Thalidomide—Arrhythmia—Betamethasone—allergic rhinitis	4.27e-05	0.000352	CcSEcCtD
Thalidomide—FGFR2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.27e-05	0.00115	CbGpPWpGaD
Thalidomide—Ill-defined disorder—Triamcinolone—allergic rhinitis	4.26e-05	0.000351	CcSEcCtD
Thalidomide—Ill-defined disorder—Methylprednisolone—allergic rhinitis	4.25e-05	0.00035	CcSEcCtD
Thalidomide—Alopecia—Betamethasone—allergic rhinitis	4.23e-05	0.000349	CcSEcCtD
Thalidomide—Alopecia—Dexamethasone—allergic rhinitis	4.23e-05	0.000349	CcSEcCtD
Thalidomide—FGFR2—Signaling Pathways—PTGDR2—allergic rhinitis	4.22e-05	0.00113	CbGpPWpGaD
Thalidomide—Convulsion—Hydrocortisone—allergic rhinitis	4.22e-05	0.000348	CcSEcCtD
Thalidomide—Hypertension—Hydrocortisone—allergic rhinitis	4.21e-05	0.000347	CcSEcCtD
Thalidomide—Discomfort—Prednisolone—allergic rhinitis	4.2e-05	0.000346	CcSEcCtD
Thalidomide—Angioedema—Triamcinolone—allergic rhinitis	4.19e-05	0.000346	CcSEcCtD
Thalidomide—Angioedema—Methylprednisolone—allergic rhinitis	4.18e-05	0.000345	CcSEcCtD
Thalidomide—FGFR2—Immune System—HLA-G—allergic rhinitis	4.15e-05	0.00111	CbGpPWpGaD
Thalidomide—Myalgia—Hydrocortisone—allergic rhinitis	4.15e-05	0.000342	CcSEcCtD
Thalidomide—Malaise—Triamcinolone—allergic rhinitis	4.14e-05	0.000341	CcSEcCtD
Thalidomide—Anxiety—Hydrocortisone—allergic rhinitis	4.13e-05	0.000341	CcSEcCtD
Thalidomide—Malaise—Methylprednisolone—allergic rhinitis	4.13e-05	0.000341	CcSEcCtD
Thalidomide—Vertigo—Triamcinolone—allergic rhinitis	4.12e-05	0.00034	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	4.12e-05	0.00034	CcSEcCtD
Thalidomide—Syncope—Triamcinolone—allergic rhinitis	4.11e-05	0.000339	CcSEcCtD
Thalidomide—Vertigo—Methylprednisolone—allergic rhinitis	4.11e-05	0.000339	CcSEcCtD
Thalidomide—Syncope—Methylprednisolone—allergic rhinitis	4.11e-05	0.000339	CcSEcCtD
Thalidomide—Discomfort—Hydrocortisone—allergic rhinitis	4.1e-05	0.000338	CcSEcCtD
Thalidomide—Oedema—Prednisolone—allergic rhinitis	4.07e-05	0.000336	CcSEcCtD
Thalidomide—Loss of consciousness—Triamcinolone—allergic rhinitis	4.03e-05	0.000333	CcSEcCtD
Thalidomide—Loss of consciousness—Methylprednisolone—allergic rhinitis	4.02e-05	0.000332	CcSEcCtD
Thalidomide—Shock—Prednisolone—allergic rhinitis	4.01e-05	0.00033	CcSEcCtD
Thalidomide—Cough—Triamcinolone—allergic rhinitis	4e-05	0.00033	CcSEcCtD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.99e-05	0.00107	CbGpPWpGaD
Thalidomide—Oedema—Hydrocortisone—allergic rhinitis	3.98e-05	0.000328	CcSEcCtD
Thalidomide—Convulsion—Triamcinolone—allergic rhinitis	3.97e-05	0.000328	CcSEcCtD
Thalidomide—Tachycardia—Prednisolone—allergic rhinitis	3.97e-05	0.000328	CcSEcCtD
Thalidomide—Convulsion—Methylprednisolone—allergic rhinitis	3.97e-05	0.000327	CcSEcCtD
Thalidomide—Hypertension—Triamcinolone—allergic rhinitis	3.96e-05	0.000327	CcSEcCtD
Thalidomide—Hypertension—Methylprednisolone—allergic rhinitis	3.95e-05	0.000326	CcSEcCtD
Thalidomide—Infection—Hydrocortisone—allergic rhinitis	3.95e-05	0.000326	CcSEcCtD
Thalidomide—Hyperhidrosis—Prednisolone—allergic rhinitis	3.94e-05	0.000325	CcSEcCtD
Thalidomide—Shock—Hydrocortisone—allergic rhinitis	3.91e-05	0.000323	CcSEcCtD
Thalidomide—Myalgia—Triamcinolone—allergic rhinitis	3.91e-05	0.000322	CcSEcCtD
Thalidomide—Nervous system disorder—Hydrocortisone—allergic rhinitis	3.9e-05	0.000322	CcSEcCtD
Thalidomide—Myalgia—Methylprednisolone—allergic rhinitis	3.9e-05	0.000322	CcSEcCtD
Thalidomide—Arthralgia—Methylprednisolone—allergic rhinitis	3.9e-05	0.000322	CcSEcCtD
Thalidomide—Anxiety—Methylprednisolone—allergic rhinitis	3.88e-05	0.00032	CcSEcCtD
Thalidomide—Tachycardia—Hydrocortisone—allergic rhinitis	3.88e-05	0.00032	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	3.87e-05	0.000319	CcSEcCtD
Thalidomide—Skin disorder—Hydrocortisone—allergic rhinitis	3.86e-05	0.000319	CcSEcCtD
Thalidomide—Ill-defined disorder—Betamethasone—allergic rhinitis	3.86e-05	0.000319	CcSEcCtD
Thalidomide—Ill-defined disorder—Dexamethasone—allergic rhinitis	3.86e-05	0.000319	CcSEcCtD
Thalidomide—Discomfort—Triamcinolone—allergic rhinitis	3.86e-05	0.000318	CcSEcCtD
Thalidomide—Discomfort—Methylprednisolone—allergic rhinitis	3.85e-05	0.000318	CcSEcCtD
Thalidomide—Hyperhidrosis—Hydrocortisone—allergic rhinitis	3.84e-05	0.000317	CcSEcCtD
Thalidomide—Dry mouth—Triamcinolone—allergic rhinitis	3.82e-05	0.000315	CcSEcCtD
Thalidomide—Angioedema—Betamethasone—allergic rhinitis	3.8e-05	0.000314	CcSEcCtD
Thalidomide—Angioedema—Dexamethasone—allergic rhinitis	3.8e-05	0.000314	CcSEcCtD
Thalidomide—Anorexia—Hydrocortisone—allergic rhinitis	3.79e-05	0.000313	CcSEcCtD
Thalidomide—Confusional state—Methylprednisolone—allergic rhinitis	3.77e-05	0.000311	CcSEcCtD
Thalidomide—Malaise—Dexamethasone—allergic rhinitis	3.75e-05	0.00031	CcSEcCtD
Thalidomide—Malaise—Betamethasone—allergic rhinitis	3.75e-05	0.00031	CcSEcCtD
Thalidomide—Oedema—Triamcinolone—allergic rhinitis	3.74e-05	0.000309	CcSEcCtD
Thalidomide—Vertigo—Dexamethasone—allergic rhinitis	3.74e-05	0.000309	CcSEcCtD
Thalidomide—Vertigo—Betamethasone—allergic rhinitis	3.74e-05	0.000309	CcSEcCtD
Thalidomide—Syncope—Betamethasone—allergic rhinitis	3.73e-05	0.000308	CcSEcCtD
Thalidomide—Syncope—Dexamethasone—allergic rhinitis	3.73e-05	0.000308	CcSEcCtD
Thalidomide—Infection—Triamcinolone—allergic rhinitis	3.72e-05	0.000307	CcSEcCtD
Thalidomide—Hypotension—Hydrocortisone—allergic rhinitis	3.72e-05	0.000307	CcSEcCtD
Thalidomide—Infection—Methylprednisolone—allergic rhinitis	3.71e-05	0.000306	CcSEcCtD
Thalidomide—TNF—MAPK Signaling Pathway—TGFB1—allergic rhinitis	3.69e-05	0.000991	CbGpPWpGaD
Thalidomide—Shock—Triamcinolone—allergic rhinitis	3.68e-05	0.000304	CcSEcCtD
Thalidomide—Insomnia—Prednisolone—allergic rhinitis	3.68e-05	0.000304	CcSEcCtD
Thalidomide—Shock—Methylprednisolone—allergic rhinitis	3.68e-05	0.000303	CcSEcCtD
Thalidomide—TNF—Developmental Biology—SMAD3—allergic rhinitis	3.67e-05	0.000987	CbGpPWpGaD
Thalidomide—Nervous system disorder—Methylprednisolone—allergic rhinitis	3.66e-05	0.000302	CcSEcCtD
Thalidomide—Loss of consciousness—Dexamethasone—allergic rhinitis	3.66e-05	0.000302	CcSEcCtD
Thalidomide—Loss of consciousness—Betamethasone—allergic rhinitis	3.66e-05	0.000302	CcSEcCtD
Thalidomide—Paraesthesia—Prednisolone—allergic rhinitis	3.66e-05	0.000302	CcSEcCtD
Thalidomide—Tachycardia—Triamcinolone—allergic rhinitis	3.65e-05	0.000301	CcSEcCtD
Thalidomide—Tachycardia—Methylprednisolone—allergic rhinitis	3.65e-05	0.000301	CcSEcCtD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	3.64e-05	0.000977	CbGpPWpGaD
Thalidomide—Skin disorder—Methylprednisolone—allergic rhinitis	3.63e-05	0.000299	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	3.62e-05	0.000299	CcSEcCtD
Thalidomide—Hyperhidrosis—Triamcinolone—allergic rhinitis	3.62e-05	0.000299	CcSEcCtD
Thalidomide—Hyperhidrosis—Methylprednisolone—allergic rhinitis	3.61e-05	0.000298	CcSEcCtD
Thalidomide—Convulsion—Betamethasone—allergic rhinitis	3.61e-05	0.000298	CcSEcCtD
Thalidomide—Convulsion—Dexamethasone—allergic rhinitis	3.61e-05	0.000298	CcSEcCtD
Thalidomide—FGFR2—Signaling by NGF—NFKB1—allergic rhinitis	3.6e-05	0.000968	CbGpPWpGaD
Thalidomide—Insomnia—Hydrocortisone—allergic rhinitis	3.6e-05	0.000297	CcSEcCtD
Thalidomide—Hypertension—Dexamethasone—allergic rhinitis	3.59e-05	0.000296	CcSEcCtD
Thalidomide—Hypertension—Betamethasone—allergic rhinitis	3.59e-05	0.000296	CcSEcCtD
Thalidomide—Paraesthesia—Hydrocortisone—allergic rhinitis	3.57e-05	0.000295	CcSEcCtD
Thalidomide—Myalgia—Dexamethasone—allergic rhinitis	3.54e-05	0.000292	CcSEcCtD
Thalidomide—Myalgia—Betamethasone—allergic rhinitis	3.54e-05	0.000292	CcSEcCtD
Thalidomide—Anxiety—Betamethasone—allergic rhinitis	3.53e-05	0.000291	CcSEcCtD
Thalidomide—Anxiety—Dexamethasone—allergic rhinitis	3.53e-05	0.000291	CcSEcCtD
Thalidomide—NFKB1—Immune System—IL5—allergic rhinitis	3.52e-05	0.000947	CbGpPWpGaD
Thalidomide—Discomfort—Betamethasone—allergic rhinitis	3.5e-05	0.000289	CcSEcCtD
Thalidomide—Discomfort—Dexamethasone—allergic rhinitis	3.5e-05	0.000289	CcSEcCtD
Thalidomide—Dyspepsia—Hydrocortisone—allergic rhinitis	3.5e-05	0.000289	CcSEcCtD
Thalidomide—NFKB1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.49e-05	0.000939	CbGpPWpGaD
Thalidomide—Hypotension—Methylprednisolone—allergic rhinitis	3.49e-05	0.000288	CcSEcCtD
Thalidomide—Pain—Prednisolone—allergic rhinitis	3.48e-05	0.000287	CcSEcCtD
Thalidomide—Decreased appetite—Hydrocortisone—allergic rhinitis	3.46e-05	0.000285	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	3.43e-05	0.000283	CcSEcCtD
Thalidomide—Fatigue—Hydrocortisone—allergic rhinitis	3.43e-05	0.000283	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	3.41e-05	0.000281	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	3.4e-05	0.000281	CcSEcCtD
Thalidomide—Pain—Hydrocortisone—allergic rhinitis	3.4e-05	0.000281	CcSEcCtD
Thalidomide—Oedema—Betamethasone—allergic rhinitis	3.4e-05	0.00028	CcSEcCtD
Thalidomide—Oedema—Dexamethasone—allergic rhinitis	3.4e-05	0.00028	CcSEcCtD
Thalidomide—Insomnia—Triamcinolone—allergic rhinitis	3.39e-05	0.000279	CcSEcCtD
Thalidomide—Insomnia—Methylprednisolone—allergic rhinitis	3.38e-05	0.000279	CcSEcCtD
Thalidomide—Infection—Dexamethasone—allergic rhinitis	3.38e-05	0.000278	CcSEcCtD
Thalidomide—Infection—Betamethasone—allergic rhinitis	3.38e-05	0.000278	CcSEcCtD
Thalidomide—NFKB1—Signaling Pathways—CCL11—allergic rhinitis	3.37e-05	0.000906	CbGpPWpGaD
Thalidomide—Paraesthesia—Triamcinolone—allergic rhinitis	3.36e-05	0.000277	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisolone—allergic rhinitis	3.36e-05	0.000277	CcSEcCtD
Thalidomide—Paraesthesia—Methylprednisolone—allergic rhinitis	3.35e-05	0.000277	CcSEcCtD
Thalidomide—FGFR2—Immune System—IL5—allergic rhinitis	3.34e-05	0.000899	CbGpPWpGaD
Thalidomide—Shock—Betamethasone—allergic rhinitis	3.34e-05	0.000276	CcSEcCtD
Thalidomide—Shock—Dexamethasone—allergic rhinitis	3.34e-05	0.000276	CcSEcCtD
Thalidomide—Dyspnoea—Triamcinolone—allergic rhinitis	3.34e-05	0.000275	CcSEcCtD
Thalidomide—Nervous system disorder—Dexamethasone—allergic rhinitis	3.33e-05	0.000275	CcSEcCtD
Thalidomide—Nervous system disorder—Betamethasone—allergic rhinitis	3.33e-05	0.000275	CcSEcCtD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.33e-05	0.000894	CbGpPWpGaD
Thalidomide—Thrombocytopenia—Dexamethasone—allergic rhinitis	3.33e-05	0.000274	CcSEcCtD
Thalidomide—Thrombocytopenia—Betamethasone—allergic rhinitis	3.33e-05	0.000274	CcSEcCtD
Thalidomide—Tachycardia—Betamethasone—allergic rhinitis	3.32e-05	0.000274	CcSEcCtD
Thalidomide—Tachycardia—Dexamethasone—allergic rhinitis	3.32e-05	0.000274	CcSEcCtD
Thalidomide—FGFR2—Signaling Pathways—CYSLTR1—allergic rhinitis	3.31e-05	0.00089	CbGpPWpGaD
Thalidomide—Dyspepsia—Triamcinolone—allergic rhinitis	3.3e-05	0.000272	CcSEcCtD
Thalidomide—Dyspepsia—Methylprednisolone—allergic rhinitis	3.29e-05	0.000271	CcSEcCtD
Thalidomide—Hyperhidrosis—Betamethasone—allergic rhinitis	3.28e-05	0.000271	CcSEcCtD
Thalidomide—Hyperhidrosis—Dexamethasone—allergic rhinitis	3.28e-05	0.000271	CcSEcCtD
Thalidomide—NFKB1—Adaptive Immune System—ICAM1—allergic rhinitis	3.28e-05	0.000882	CbGpPWpGaD
Thalidomide—Feeling abnormal—Hydrocortisone—allergic rhinitis	3.28e-05	0.00027	CcSEcCtD
Thalidomide—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	3.25e-05	0.000268	CcSEcCtD
Thalidomide—Anorexia—Betamethasone—allergic rhinitis	3.24e-05	0.000267	CcSEcCtD
Thalidomide—Anorexia—Dexamethasone—allergic rhinitis	3.24e-05	0.000267	CcSEcCtD
Thalidomide—Urticaria—Prednisolone—allergic rhinitis	3.23e-05	0.000267	CcSEcCtD
Thalidomide—Fatigue—Triamcinolone—allergic rhinitis	3.23e-05	0.000266	CcSEcCtD
Thalidomide—Fatigue—Methylprednisolone—allergic rhinitis	3.22e-05	0.000266	CcSEcCtD
Thalidomide—Pain—Triamcinolone—allergic rhinitis	3.2e-05	0.000264	CcSEcCtD
Thalidomide—FGFR2—Signaling Pathways—CCL11—allergic rhinitis	3.2e-05	0.00086	CbGpPWpGaD
Thalidomide—Hypotension—Betamethasone—allergic rhinitis	3.17e-05	0.000262	CcSEcCtD
Thalidomide—Hypotension—Dexamethasone—allergic rhinitis	3.17e-05	0.000262	CcSEcCtD
Thalidomide—Urticaria—Hydrocortisone—allergic rhinitis	3.16e-05	0.000261	CcSEcCtD
Thalidomide—Abdominal pain—Hydrocortisone—allergic rhinitis	3.14e-05	0.000259	CcSEcCtD
Thalidomide—Body temperature increased—Hydrocortisone—allergic rhinitis	3.14e-05	0.000259	CcSEcCtD
Thalidomide—FGFR2—Adaptive Immune System—ICAM1—allergic rhinitis	3.12e-05	0.000837	CbGpPWpGaD
Thalidomide—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	3.1e-05	0.000255	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	3.1e-05	0.000255	CcSEcCtD
Thalidomide—Feeling abnormal—Triamcinolone—allergic rhinitis	3.09e-05	0.000255	CcSEcCtD
Thalidomide—Feeling abnormal—Methylprednisolone—allergic rhinitis	3.08e-05	0.000254	CcSEcCtD
Thalidomide—Insomnia—Betamethasone—allergic rhinitis	3.07e-05	0.000254	CcSEcCtD
Thalidomide—Insomnia—Dexamethasone—allergic rhinitis	3.07e-05	0.000254	CcSEcCtD
Thalidomide—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	3.05e-05	0.000252	CcSEcCtD
Thalidomide—Paraesthesia—Dexamethasone—allergic rhinitis	3.05e-05	0.000252	CcSEcCtD
Thalidomide—Paraesthesia—Betamethasone—allergic rhinitis	3.05e-05	0.000252	CcSEcCtD
Thalidomide—PTGS2—Spinal Cord Injury—TGFB1—allergic rhinitis	3.03e-05	0.000813	CbGpPWpGaD
Thalidomide—Hypersensitivity—Prednisolone—allergic rhinitis	3e-05	0.000247	CcSEcCtD
Thalidomide—Dyspepsia—Dexamethasone—allergic rhinitis	2.99e-05	0.000247	CcSEcCtD
Thalidomide—Dyspepsia—Betamethasone—allergic rhinitis	2.99e-05	0.000247	CcSEcCtD
Thalidomide—Urticaria—Triamcinolone—allergic rhinitis	2.97e-05	0.000245	CcSEcCtD
Thalidomide—Urticaria—Methylprednisolone—allergic rhinitis	2.97e-05	0.000245	CcSEcCtD
Thalidomide—Body temperature increased—Triamcinolone—allergic rhinitis	2.96e-05	0.000244	CcSEcCtD
Thalidomide—Abdominal pain—Methylprednisolone—allergic rhinitis	2.95e-05	0.000244	CcSEcCtD
Thalidomide—Decreased appetite—Dexamethasone—allergic rhinitis	2.95e-05	0.000244	CcSEcCtD
Thalidomide—Decreased appetite—Betamethasone—allergic rhinitis	2.95e-05	0.000244	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	2.93e-05	0.000242	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Betamethasone—allergic rhinitis	2.93e-05	0.000242	CcSEcCtD
Thalidomide—Hypersensitivity—Hydrocortisone—allergic rhinitis	2.93e-05	0.000242	CcSEcCtD
Thalidomide—Fatigue—Betamethasone—allergic rhinitis	2.93e-05	0.000242	CcSEcCtD
Thalidomide—Fatigue—Dexamethasone—allergic rhinitis	2.93e-05	0.000242	CcSEcCtD
Thalidomide—Pain—Betamethasone—allergic rhinitis	2.91e-05	0.00024	CcSEcCtD
Thalidomide—Pain—Dexamethasone—allergic rhinitis	2.91e-05	0.00024	CcSEcCtD
Thalidomide—Asthenia—Hydrocortisone—allergic rhinitis	2.85e-05	0.000235	CcSEcCtD
Thalidomide—Pruritus—Hydrocortisone—allergic rhinitis	2.81e-05	0.000232	CcSEcCtD
Thalidomide—Feeling abnormal—Dexamethasone—allergic rhinitis	2.8e-05	0.000231	CcSEcCtD
Thalidomide—Feeling abnormal—Betamethasone—allergic rhinitis	2.8e-05	0.000231	CcSEcCtD
Thalidomide—Gastrointestinal pain—Dexamethasone—allergic rhinitis	2.78e-05	0.000229	CcSEcCtD
Thalidomide—Gastrointestinal pain—Betamethasone—allergic rhinitis	2.78e-05	0.000229	CcSEcCtD
Thalidomide—Hypersensitivity—Triamcinolone—allergic rhinitis	2.76e-05	0.000228	CcSEcCtD
Thalidomide—Hypersensitivity—Methylprednisolone—allergic rhinitis	2.75e-05	0.000227	CcSEcCtD
Thalidomide—NFKB1—Immune System—HLA-DQB1—allergic rhinitis	2.73e-05	0.000733	CbGpPWpGaD
Thalidomide—Diarrhoea—Hydrocortisone—allergic rhinitis	2.72e-05	0.000224	CcSEcCtD
Thalidomide—Urticaria—Betamethasone—allergic rhinitis	2.7e-05	0.000223	CcSEcCtD
Thalidomide—Urticaria—Dexamethasone—allergic rhinitis	2.7e-05	0.000223	CcSEcCtD
Thalidomide—Dizziness—Prednisolone—allergic rhinitis	2.69e-05	0.000222	CcSEcCtD
Thalidomide—Asthenia—Triamcinolone—allergic rhinitis	2.69e-05	0.000222	CcSEcCtD
Thalidomide—Abdominal pain—Betamethasone—allergic rhinitis	2.69e-05	0.000222	CcSEcCtD
Thalidomide—Abdominal pain—Dexamethasone—allergic rhinitis	2.69e-05	0.000222	CcSEcCtD
Thalidomide—Body temperature increased—Betamethasone—allergic rhinitis	2.69e-05	0.000222	CcSEcCtD
Thalidomide—Body temperature increased—Dexamethasone—allergic rhinitis	2.69e-05	0.000222	CcSEcCtD
Thalidomide—Asthenia—Methylprednisolone—allergic rhinitis	2.68e-05	0.000221	CcSEcCtD
Thalidomide—Pruritus—Triamcinolone—allergic rhinitis	2.65e-05	0.000219	CcSEcCtD
Thalidomide—Pruritus—Methylprednisolone—allergic rhinitis	2.64e-05	0.000218	CcSEcCtD
Thalidomide—Dizziness—Hydrocortisone—allergic rhinitis	2.63e-05	0.000217	CcSEcCtD
Thalidomide—FGFR2—Immune System—HLA-DQB1—allergic rhinitis	2.59e-05	0.000696	CbGpPWpGaD
Thalidomide—Rash—Prednisolone—allergic rhinitis	2.57e-05	0.000212	CcSEcCtD
Thalidomide—Dermatitis—Prednisolone—allergic rhinitis	2.56e-05	0.000212	CcSEcCtD
Thalidomide—Diarrhoea—Methylprednisolone—allergic rhinitis	2.56e-05	0.000211	CcSEcCtD
Thalidomide—Headache—Prednisolone—allergic rhinitis	2.55e-05	0.00021	CcSEcCtD
Thalidomide—Vomiting—Hydrocortisone—allergic rhinitis	2.53e-05	0.000209	CcSEcCtD
Thalidomide—NFKB1—Innate Immune System—CD4—allergic rhinitis	2.51e-05	0.000675	CbGpPWpGaD
Thalidomide—Rash—Hydrocortisone—allergic rhinitis	2.51e-05	0.000207	CcSEcCtD
Thalidomide—Dermatitis—Hydrocortisone—allergic rhinitis	2.5e-05	0.000207	CcSEcCtD
Thalidomide—Headache—Hydrocortisone—allergic rhinitis	2.49e-05	0.000206	CcSEcCtD
Thalidomide—Dizziness—Triamcinolone—allergic rhinitis	2.48e-05	0.000204	CcSEcCtD
Thalidomide—Dizziness—Methylprednisolone—allergic rhinitis	2.47e-05	0.000204	CcSEcCtD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.47e-05	0.000664	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TAC1—allergic rhinitis	2.45e-05	0.000659	CbGpPWpGaD
Thalidomide—Asthenia—Betamethasone—allergic rhinitis	2.44e-05	0.000201	CcSEcCtD
Thalidomide—Asthenia—Dexamethasone—allergic rhinitis	2.44e-05	0.000201	CcSEcCtD
Thalidomide—Nausea—Prednisolone—allergic rhinitis	2.42e-05	0.0002	CcSEcCtD
Thalidomide—NFKB1—Adaptive Immune System—CD4—allergic rhinitis	2.41e-05	0.000648	CbGpPWpGaD
Thalidomide—Pruritus—Dexamethasone—allergic rhinitis	2.4e-05	0.000198	CcSEcCtD
Thalidomide—Pruritus—Betamethasone—allergic rhinitis	2.4e-05	0.000198	CcSEcCtD
Thalidomide—FGFR2—Innate Immune System—CD4—allergic rhinitis	2.38e-05	0.000641	CbGpPWpGaD
Thalidomide—Vomiting—Triamcinolone—allergic rhinitis	2.38e-05	0.000196	CcSEcCtD
Thalidomide—Vomiting—Methylprednisolone—allergic rhinitis	2.38e-05	0.000196	CcSEcCtD
Thalidomide—Nausea—Hydrocortisone—allergic rhinitis	2.36e-05	0.000195	CcSEcCtD
Thalidomide—Rash—Triamcinolone—allergic rhinitis	2.36e-05	0.000195	CcSEcCtD
Thalidomide—Dermatitis—Triamcinolone—allergic rhinitis	2.36e-05	0.000195	CcSEcCtD
Thalidomide—Rash—Methylprednisolone—allergic rhinitis	2.36e-05	0.000194	CcSEcCtD
Thalidomide—Dermatitis—Methylprednisolone—allergic rhinitis	2.35e-05	0.000194	CcSEcCtD
Thalidomide—Headache—Triamcinolone—allergic rhinitis	2.35e-05	0.000194	CcSEcCtD
Thalidomide—Headache—Methylprednisolone—allergic rhinitis	2.34e-05	0.000193	CcSEcCtD
Thalidomide—FGFR2—Signaling Pathways—TAC1—allergic rhinitis	2.33e-05	0.000625	CbGpPWpGaD
Thalidomide—Diarrhoea—Betamethasone—allergic rhinitis	2.32e-05	0.000192	CcSEcCtD
Thalidomide—Diarrhoea—Dexamethasone—allergic rhinitis	2.32e-05	0.000192	CcSEcCtD
Thalidomide—FGFR2—Adaptive Immune System—CD4—allergic rhinitis	2.29e-05	0.000615	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL5—allergic rhinitis	2.28e-05	0.000612	CbGpPWpGaD
Thalidomide—Dizziness—Dexamethasone—allergic rhinitis	2.25e-05	0.000185	CcSEcCtD
Thalidomide—Dizziness—Betamethasone—allergic rhinitis	2.25e-05	0.000185	CcSEcCtD
Thalidomide—Nausea—Triamcinolone—allergic rhinitis	2.22e-05	0.000183	CcSEcCtD
Thalidomide—Nausea—Methylprednisolone—allergic rhinitis	2.22e-05	0.000183	CcSEcCtD
Thalidomide—FGFR2—Disease—SMAD3—allergic rhinitis	2.17e-05	0.000584	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL5—allergic rhinitis	2.16e-05	0.000581	CbGpPWpGaD
Thalidomide—Vomiting—Betamethasone—allergic rhinitis	2.16e-05	0.000178	CcSEcCtD
Thalidomide—Vomiting—Dexamethasone—allergic rhinitis	2.16e-05	0.000178	CcSEcCtD
Thalidomide—Rash—Dexamethasone—allergic rhinitis	2.14e-05	0.000177	CcSEcCtD
Thalidomide—Rash—Betamethasone—allergic rhinitis	2.14e-05	0.000177	CcSEcCtD
Thalidomide—Dermatitis—Betamethasone—allergic rhinitis	2.14e-05	0.000177	CcSEcCtD
Thalidomide—Dermatitis—Dexamethasone—allergic rhinitis	2.14e-05	0.000177	CcSEcCtD
Thalidomide—Headache—Dexamethasone—allergic rhinitis	2.13e-05	0.000176	CcSEcCtD
Thalidomide—Headache—Betamethasone—allergic rhinitis	2.13e-05	0.000176	CcSEcCtD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.06e-05	0.000553	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—NFKB1—allergic rhinitis	2.05e-05	0.000552	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TGFB1—allergic rhinitis	2.04e-05	0.000549	CbGpPWpGaD
Thalidomide—Nausea—Dexamethasone—allergic rhinitis	2.02e-05	0.000166	CcSEcCtD
Thalidomide—Nausea—Betamethasone—allergic rhinitis	2.02e-05	0.000166	CcSEcCtD
Thalidomide—NFKB1—Immune System—ICAM1—allergic rhinitis	1.99e-05	0.000535	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—NFKB1—allergic rhinitis	1.97e-05	0.00053	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—ICAM1—allergic rhinitis	1.89e-05	0.000508	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—NFKB1—allergic rhinitis	1.87e-05	0.000502	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—SMAD3—allergic rhinitis	1.6e-05	0.000431	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—TGFB1—allergic rhinitis	1.56e-05	0.000418	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—SMAD3—allergic rhinitis	1.52e-05	0.000409	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD4—allergic rhinitis	1.46e-05	0.000393	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD4—allergic rhinitis	1.39e-05	0.000373	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD4—allergic rhinitis	1.28e-05	0.000344	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NFKB1—allergic rhinitis	1.2e-05	0.000321	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SMAD3—allergic rhinitis	1.08e-05	0.00029	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TGFB1—allergic rhinitis	9.2e-06	0.000247	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NFKB1—allergic rhinitis	7.74e-06	0.000208	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TGFB1—allergic rhinitis	6.79e-06	0.000182	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TGFB1—allergic rhinitis	6.44e-06	0.000173	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD4—allergic rhinitis	6.37e-06	0.000171	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TGFB1—allergic rhinitis	4.57e-06	0.000123	CbGpPWpGaD
